Is there a role for endothelin antagonists in diabetic renal disease?
Jandeleit-Dahm
K
K
Department of Medicine, University of Melbourne, Heidelberg West, Australia.
Allen
T J
TJ
Youssef
S
S
Gilbert
R E
RE
Cooper
M E
ME
D000818:Animals; D016282:Aspartic Acid Endopeptidases / Q000378:metabolism; D048909:Diabetes Complications; D003928:Diabetic Nephropathies / Q000188:drug therapy / Q000503:physiopathology*; D004195:Disease Models, Animal; D065128:Endothelin Receptor Antagonists; D000072396:Endothelin-Converting Enzymes; D016232:Endothelins / Q000502:physiology*; D006801:Humans; D006977:Hypertension, Renal / Q000209:etiology / Q000503:physiopathology; D008666:Metalloendopeptidases; D051381:Rats
D065128:Endothelin Receptor Antagonists; D016232:Endothelins; D016282:Aspartic Acid Endopeptidases; D008666:Metalloendopeptidases; D000072396:Endothelin-Converting Enzymes